Smyth MJ - Search Results

1

CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Delconte RB, Kolesnik TB, Dagley LF, Rautela J, Shi W, Putz EM, Stannard K, Zhang JG, Teh C, Firth M, Ushiki T, Andoniou CE, Degli-Esposti MA, Sharp PP, Sanvitale CE, Infusini G, Liau NP, Linossi EM, Burns CJ, Carotta S, Gray DH, Seillet C, Hutchinson DS, Belz GT, Webb AI, Alexander WS, Li SS, Bullock AN, Babon JJ, Smyth MJ, Nicholson SE, Huntington ND. Delconte RB, et al. Among authors: smyth mj. Nat Immunol. 2016 Jul;17(7):816-24. doi: 10.1038/ni.3470. Epub 2016 May 23. Nat Immunol. 2016. PMID: 27213690

2

Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation.

O'Shea JJ, McVicar DW, Bailey TL, Burns C, Smyth MJ. O'Shea JJ, et al. Among authors: smyth mj. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10306-10. doi: 10.1073/pnas.89.21.10306. Proc Natl Acad Sci U S A. 1992. PMID: 1279675 Free PMC article.

3

NK cells and apoptosis.

Warren HS, Smyth MJ. Warren HS, et al. Among authors: smyth mj. Immunol Cell Biol. 1999 Feb;77(1):64-75. doi: 10.1046/j.1440-1711.1999.00790.x. Immunol Cell Biol. 1999. PMID: 10101688 Review.

4

Perforin is a major contributor to NK cell control of tumor metastasis.

Smyth MJ, Thia KY, Cretney E, Kelly JM, Snook MB, Forbes CA, Scalzo AA. Smyth MJ, et al. J Immunol. 1999 Jun 1;162(11):6658-62. J Immunol. 1999. PMID: 10352283

5

Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice.

Smyth MJ, Johnstone RW, Cretney E, Haynes NM, Sedgwick JD, Korner H, Poulton LD, Baxter AG. Smyth MJ, et al. J Immunol. 1999 Aug 1;163(3):1350-3. J Immunol. 1999. PMID: 10415034

6

m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.

Cretney E, Degli-Esposti MA, Densley EH, Farrell HE, Davis-Poynter NJ, Smyth MJ. Cretney E, et al. Among authors: smyth mj. J Exp Med. 1999 Aug 2;190(3):435-44. doi: 10.1084/jem.190.3.435. J Exp Med. 1999. PMID: 10430631 Free PMC article.

7

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent.

Smyth MJ, Taniguchi M, Street SE. Smyth MJ, et al. J Immunol. 2000 Sep 1;165(5):2665-70. doi: 10.4049/jimmunol.165.5.2665. J Immunol. 2000. PMID: 10946296

8

Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.

Davis JE, Smyth MJ, Trapani JA. Davis JE, et al. Among authors: smyth mj. Eur J Immunol. 2001 Jan;31(1):39-47. doi: 10.1002/1521-4141(200101)31:1<39::aid-immu39>3.0.co;2-1. Eur J Immunol. 2001. PMID: 11169436 Free article.

9

A fresh look at tumor immunosurveillance and immunotherapy.

Smyth MJ, Godfrey DI, Trapani JA. Smyth MJ, et al. Nat Immunol. 2001 Apr;2(4):293-9. doi: 10.1038/86297. Nat Immunol. 2001. PMID: 11276199 Review.

10

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

Smyth MJ, Crowe NY, Godfrey DI. Smyth MJ, et al. Int Immunol. 2001 Apr;13(4):459-63. doi: 10.1093/intimm/13.4.459. Int Immunol. 2001. PMID: 11282985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

662 results

Search Page